NCT02748785View on ClinicalTrials.gov

MTX Discontinuation and Vaccine Response

PHASE4CompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Methotrexate

Methotrexate will be continued

BIOLOGICAL

Seasonal Influenza vaccine

all subjects will be vaccinated with a seasonal influenza vaccine

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02748785 - MTX Discontinuation and Vaccine Response | Biotech Hunter | Biotech Hunter